Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;41(3):383-388.
doi: 10.1007/s13410-021-00930-y. Epub 2021 Feb 9.

Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients

Affiliations

Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients

Leila Moftakhar et al. Int J Diabetes Dev Ctries. 2021 Jul.

Abstract

Objectives and background: People with diabetes (PWD) are one of the high-risk groups for coronavirus disease 2019 (COVID-19) infection, increasing the disease mortality. This study was aimed to compare the epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic individuals.

Methods: In this retrospective observational study, the epidemiological characteristics of the two groups of diabetic (n=1365) and non-diabetic (n=15,026) subjects with definite diagnosis of COVID-19 in the southwestern region of Iran were compared. All clinical signs and comorbidities of the patients were evaluated. Chi-square test was used to examine the differences in qualitative variables between diabetic and non-diabetic groups.

Results: Of 16,391 enrolled subjects, 8.3% had diabetes, and 28.3% of COVID-19-related deaths occurred in diabetics. Also, the mortality rate among diabetics was reported as 14.3%. The average age of diabetic patients and non-diabetic patients was 59 and 37 years, respectively. The odds of fever, cough, shortness of breath, headache, and underlying diseases, such as hypertension, cardiovascular disease, chronic lung disease, immune deficiency, and hyperlipidemia, were significantly higher in diabetic patients than in non-diabetics.

Conclusion: Diabetes is associated with increased mortality rate in patients with COVID-19 and is considered as a major risk factor for COVID-19 infection, posing a major public health challenge for health policymakers in managing and controlling the disease. Therefore, development of prevention and treatment strategies aimed at reducing COVID-19 morbidity and mortality in diabetes patients is of significant importance.

Keywords: COVID-19; Diabetes; Mortality.

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare that they have no competing interests.

References

    1. Moradi A, Hasani J. Comparative study of emotional regulation, self-control and defense mechanisms in cardiovascular patients, diabetic patients and normal people. Iranian J Psychiatr Nurs. 2019;6(1):43–52.
    1. Shahbeik S, Taghavijoorabchi F, Abroshan F, Naseri M. Effectiveness of group-based cognitive therapy based on mindfulness on family function and marital adaptation of couples with type II diabetes. Iran J Nurs Res. 2019;13(6):68–75.
    1. Singh AK, Singh A, Shaikh A, Singh R, Misra A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020. - PMC - PubMed
    1. Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infection, Genetics and. Evolution. 2020;79:104212. - PMC - PubMed
    1. Amiri P. The role of electronic health during the Covid-19 crisis: a systematic review of literatures. J Health Biomed Inform. 2020;6(4):358–367.

LinkOut - more resources